Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Tsujimura

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Entropy (Basel, Switzerland)|December 23, 2022
Entanglement Renyi Entropy of Two Disjoint Intervals for Large <i>c</i> Liouville Field TheoryJun Tsujimura, Yasusada Nambu
Entropy (Basel, Switzerland)|December 8, 2020
Null Wave Front and Ryu-Takayanagi SurfaceJun Tsujimura, Yasusada Nambu
Clinical Ophthalmology (Auckland, N.Z.)|March 8, 2022
Real-World Data on Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 24-Month OutcomesMasahiko Shimura, Makoto Fukumatsu, Jun Tsujimura, et al.
Neuroscience Letters|July 16, 2013
NMDA receptor-dependent recruitment of calnexin to the neuronal plasma membraneMakoto Itakura, Jun Tsujimura, Saori Yamamori, et al.
Journal of Biochemistry|June 1, 2002
Nerve growth factor enhances neurotransmitter release from PC12 cells by increasing Ca(2+)-responsible secretory vesicles through the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinaseShinya Amino, Makoto Itakura, Hiroshi Ohnishi, et al.
Journal of Medical Economics|March 13, 2025
Cost-effectiveness analysis of bispecific antibody faricimab for treatment of neovascular age-related macular degeneration and diabetic macular edema in JapanYasuo Yanagi, Jun Tsujimura, Shinya Ohno, et al.
Plos One|October 30, 2025
A multicenter, single-arm study using a modified faricimab treat-and-extend regimen in patients with macular edema due to central retinal vein occlusion: RVOSTAR study design protocolMineo Kondo, Masahiko Shimura, Akitaka Tsujikawa, et al.
Plos One|October 10, 2024
Optimization of individualized faricimab dosing for patients with diabetic macular edema: Protocol for the SWAN open-label, single-arm clinical trialTakao Hirano, Toshinori Murata, Shintaro Nakao, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Entropy (Basel, Switzerland)|December 23, 2022
Entanglement Renyi Entropy of Two Disjoint Intervals for Large <i>c</i> Liouville Field TheoryJun Tsujimura, Yasusada Nambu
Entropy (Basel, Switzerland)|December 8, 2020
Null Wave Front and Ryu-Takayanagi SurfaceJun Tsujimura, Yasusada Nambu
Clinical Ophthalmology (Auckland, N.Z.)|March 8, 2022
Real-World Data on Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 24-Month OutcomesMasahiko Shimura, Makoto Fukumatsu, Jun Tsujimura, et al.
Neuroscience Letters|July 16, 2013
NMDA receptor-dependent recruitment of calnexin to the neuronal plasma membraneMakoto Itakura, Jun Tsujimura, Saori Yamamori, et al.
Journal of Biochemistry|June 1, 2002
Nerve growth factor enhances neurotransmitter release from PC12 cells by increasing Ca(2+)-responsible secretory vesicles through the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinaseShinya Amino, Makoto Itakura, Hiroshi Ohnishi, et al.
Journal of Medical Economics|March 13, 2025
Cost-effectiveness analysis of bispecific antibody faricimab for treatment of neovascular age-related macular degeneration and diabetic macular edema in JapanYasuo Yanagi, Jun Tsujimura, Shinya Ohno, et al.
Plos One|October 30, 2025
A multicenter, single-arm study using a modified faricimab treat-and-extend regimen in patients with macular edema due to central retinal vein occlusion: RVOSTAR study design protocolMineo Kondo, Masahiko Shimura, Akitaka Tsujikawa, et al.
Plos One|October 10, 2024
Optimization of individualized faricimab dosing for patients with diabetic macular edema: Protocol for the SWAN open-label, single-arm clinical trialTakao Hirano, Toshinori Murata, Shintaro Nakao, et al.
Pageof 1